Viewing Study NCT01241760

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 2:02 AM

Ignite Modification Date: 2025-12-26 @ 1:34 AM

Study NCT ID: NCT01241760

Status: COMPLETED

Last Update Posted: 2014-06-04

First Post: 2010-10-28

Is NOT Gene Therapy: True

Has Adverse Events: True

Brief Title: VX-950-C211 - A Dosing Regimen Study (Twice Daily Versus Every 8 Hours) of Telaprevir in Treatment-naïve Participants With Genotype 1 Chronic Hepatitis C Virus Infection

Sponsor: Janssen Infectious Diseases BVBA

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module Adverse Events Module Baseline Characteristics Module Participant Flow Module